Laboratory Analytical Instruments - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Laboratory industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Laboratory Analytical Instruments - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Laboratory Analytical Instruments
Corporate Insider Buy Sell Ratio (Insider Count) - Laboratory Analytical Instruments
Laboratory Analytical Instruments - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-05-21 A / Agilent Technologies, Inc. 4/A Brown Judy L A - Award D 108.91 1,677
2025-05-21 ILMN / Illumina, Inc. 4 EPSTEIN ROBERT S A - Award D 3,780
2025-05-20 SEER / Seer, Inc. 4 Horn David R. S - Sale D 2.0751 -6,760
2025-05-20 SEER / Seer, Inc. 4 Farokhzad Omid S - Sale D 2.0751 -33,663
2025-05-20 PRPO / Precipio, Inc. 4/A SANDBERG RICHARD A Roth IRA for the benefit of Richard A Sandberg P - Purchase I 8.47 4,251
2025-05-20 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A Roth IRA for the benefit of Richard A Sandberg P - Purchase I 8.47 4,251
2025-05-19 PACB / Pacific Biosciences of California, Inc. 4 Farmer Michele S - Sale D 1.001 -5,195
2025-05-19 PRPO / Precipio, Inc. 4/A SANDBERG RICHARD A Roth IRA for the benefit of Richard A Sandberg P - Purchase I 8.21 714
2025-05-19 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A Roth IRA for the benefit of Richard A Sandberg P - Purchase I 8.21 714
2025-05-19 EYPT / EyePoint Pharmaceuticals, Inc. 4 Zaderej Karen L. P - Purchase D 5.99 5,000
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 7,250
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 5,156
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 2,454
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 2,016
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Holder Michael M - Exercise D 1,454
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 19,334
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 7,854
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 4,908
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 1,981
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 4,108
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 6,758
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 14,733
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 3,683
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. M - Exercise D 8,700
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 1,024
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. M - Exercise D 25,283
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 2,416
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 1,473
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe F - Taxes D 2.69 -574
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe F - Taxes D 2.69 -399
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe F - Taxes D 2.69 -942
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. F - Taxes D 2.69 -3,389
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. F - Taxes D 2.69 -9,848
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 2.69 -2,824
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 2.69 -786
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 2.69 -2,009
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 2.69 -956
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 2.69 -1,456
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 2.69 -4,708
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 2.69 -588
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 2.69 -1,913
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 2.69 -1,093
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 2.69 -3,588
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 2.69 -1,646
2025-05-19 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 2.69 -1,219
2025-05-16 EYPT / EyePoint Pharmaceuticals, Inc. 4 Zaderej Karen L. P - Purchase D 5.81 5,000
2025-05-16 ILMN / Illumina, Inc. 4 Ullem Scott B. F - Taxes D 83.62 -1,070
2025-05-16 ILMN / Illumina, Inc. 4 DORSA CAROLINE F - Taxes D 83.62 -1,070
2025-05-15 EYPT / EyePoint Pharmaceuticals, Inc. 4 Zaderej Karen L. P - Purchase D 5.47 5,000
2025-05-15 QTRX / Quanterix Corporation 4 Sriram Vandana F - Taxes D 4.50 -229
P
Achat sur le marché public ou privé d'un titre non dérivé ou dérivé
S
Vente sur le marché public ou privé d'un titre non dérivé ou dérivé
A
Attribution, récompense ou autre acquisition de titres de l'entreprise (comme une option).
C
Conversion d'un produit dérivé
D
Vente ou transfert de titres à l'entreprise
F
Paiement du prix d'exercice ou de la dette fiscale en utilisant une partie des titres reçus de l'entreprise
G
Don de titres par ou à l'initié
K
Swaps d'actions et opérations de couverture similaires
M
Exercice ou conversion d'un titre dérivé reçu de l'entreprise (tel qu'une option)
V
Une transaction déclarée volontairement sur le formulaire 4
J
Autre (accompagnée d'une note de bas de page décrivant la transaction)